About My Health Careers Internship MedBlogs Contact us

Diabetes Drug Helps Cut Build-up of Fat in the Liver

by Hannah Joy on March 21, 2018 at 11:49 AM
Font : A-A+

Diabetes Drug Helps Cut Build-up of Fat in the Liver

Type 2 diabetes drug was found to have the potential in reducing liver fat in patients with non-alcoholic fatty liver disease (NAFLD) and high blood sugar, reveals a new study.

In people with Type 2 Diabetes, NAFLD is common and can progress to a severe liver disease known as non-alcoholic steatohepatitis.


The middle-aged adults who received empagliflozin showed an average 16.2 to 11.3 percent decrease in liver fat post 20 weeks of treatment.

On the other hand, the control group showed only a minimal decrease from 16.4 to 15.6 percent, the findings revealed.

"Despite the fact that NASH may progress to cirrhosis of the liver and liver cancer, there are no approved medications for treating NASH or NAFLD, and agents like metformin, pioglitazone, and Vitamin E have had limited success in reducing liver fat," said Ambrish Mithal, Chair of the Division of Endocrinology and Diabetes at Medanta The Medicity Hospital, Gurugram.

"Our results suggest that empagliflozin may help in treating NAFLD," Mithal added, in the paper presented at the Endocrine Society's 100th Annual meeting in Chicago.

Previous studies had established the potential of the diabetes drug empagliflozin in decreasing liver fat in rodents with a buildup of fat in the liver.

"While our findings do not prove that empagliflozin will help treat NAFLD or prevent NASH, the initial results are promising and open up the possibility that empagliflozin may provide additional benefits for patients with diabetes," Mithal said.

In the trial, the team included patients who were 40 years or older and had Type 2 diabetes and NAFLD.

They were randomly assigned to receive empagliflozin (10 milligrams per day) plus their standard medical treatment for Type 2 diabetes, such as metformin and/or insulin, or to receive only their standard treatment without empagliflozin (control group).

Empagliflozin was approved by the US Food and Drug Administration in 2014 for adults with Type 2 diabetes.

It primarily acts by increasing glucose excretion through the urine, thereby reducing blood glucose levels and body weight.

Source: IANS

News A-Z
News Category
What's New on Medindia
Is COVID-19 Vaccination during Pregnancy Safe?
Sensory Processing Disorder (SPD)
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Cholesterol Drug Toxicity Diabetes Diabetic Diet Hepatitis A Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise 

Recommended Reading
Study Says Consuming Probiotics Reduce Liver Fat
Consuming probiotics for a month helps in diminishing fat accumulation in the liver finds new ......
Liver Fat Maintains Sugar Levels in Blood, Says Animal Study
Mice in whom an enzyme called histone deacetylase 3 (HDAC3) is deleted, have massively fatty ......
Regular Exercise Reduces Liver Fat, Improves Non-Alcoholic Fatty Liver Disease
A short, moderate and daily exercise regimen, regardless of volume or intensity, benefits obese and ...
Gastrointestinal Hormones may Help Ease Symptoms of Liver Diseases
The gastrointestinal hormone can measurably improve the symptoms of non-alcoholic fatty liver ......
Cholesterol is produced by the body (liver) and is essential for normal body functioning....
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, sy...
Diabetes - Essentials
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels a...
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Di...
Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the...
Diabetic Diet
The diabetic diet most often recommended is high in dietary fiber (especially soluble fiber) and nut...
Diabetic Retinopathy
The term ‘diabetic retinopathy’ refers to changes in the retina which often occur in people with ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use